您的位置: 首页 > 农业专利 > 详情页

Specific therapy and medicament using integrin ligands for treating cancer
专利权人:
Merck Patent GmbH
发明人:
Harstrick, Andreas,Nippgen, Johannes,Stupp, Roger,Goodman, Simon,Picard, Martin Andreas,Weller, Michael,Grimm, Ulrike,Krueger, Stefan
申请号:
AU2008207095
公开号:
AU2008207095B2
申请日:
2008.01.17
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The invention relates to a combination therapy for the treatment of tumors andtumor metastases comprising administration of integrin ligands, preferablyintegrin antagonists, together with co-therapeutic agents or therapy formsthat have synergistic efficacy when administered consecutively with said ligands,such as chemotherapeutic agents and or radiation therapy. The therapy resultsin a synergistic potential increase of the inhibition effect of each individualtherapeutic on tumor cell proliferation, yielding more effective treatmentthan found by administering an individual component alone, concurrently ornot in the dosage regime of the present invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充